Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.39 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.39 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.39 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.37 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6317296 | 0.84 | DRD2 (0.41) | POLBPTGDR2SIGMAR1TMEM97 | |
| SCHEMBL5745277 | 0.83 | TACR1 (0.39) | HTR2C | |
| SCHEMBL5746790 | 0.76 | PTGDR2 (0.41) | HTR2CPOLBPKMPTGDR2SIGMAR1 | |
| SCHEMBL6311280 | 0.76 | DRD2 (0.40) | HTR2CPOLBPKMSIGMAR1TMEM97 | |
| SCHEMBL5744862 | 0.75 | CYP2D6 (0.41) | POLBPKMPTGDR2 | |
| SCHEMBL4026871 | 0.74 | HTR2C (0.42) | HTR2CPDK1PDK2PDK3PDK4 | |
| SCHEMBL4027421 | 0.73 | SMN1; SMN2 (0.43) | HTR2CPKMPTGDR2SIGMAR1TMEM97 | |
| SCHEMBL2488624 | 0.73 | PARP1 (0.46) | PKMPTGDR2PARP1SIGMAR1TMEM97 | |
| SCHEMBL4024932 | 0.73 | SMN1; SMN2 (0.43) | HTR2CPKMPTGDR2SIGMAR1TMEM97 | |
| SCHEMBL4859941 | 0.73 | PARP1 (0.46) | PKMPTGDR2PARP1SIGMAR1TMEM97 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1638935-A1 | NK1 ANTAGONIST | Pfizer Products Inc. (US) | 2006-03-29 | — | — | EP | disclosed |
| WO-2004110996-A1 | NK1 ANTAGONIST | PFIZER PRODUCTS INC. (US) | 2004-12-23 | — | — | WO | disclosed |